Page - (000130) - in Biomedical Chemistry: Current Trends and Developments

Oh, K.S., Park, S.J., Shinde, D.D., Shin, J.G., Kim, D.H., (2012) High-sensitivity liquid chromatography–tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma. Journal of Chromatography B, 895-896, 56-64. Otten, J.N., Hingorani, G.P., Hartley, D.P., Kragerud, S.D., Franklin, R.B., (2012) An In Vitro, High Throughput, Seven CYP Cocktail Inhibition Assay for the Evaluation of New Chemical Entities Using LC-MS/MS. Drug Metabolism Letters, 5(1), 17-24. Panchagnula, R., Thomas, N.S. (2000) Biopharmaceutics and pharmacokinetics in drug research. International Journal of Pharmaceutics, 201(2), 131-150. Parrrott, N., Lavè, T. (2002) Prediction of intestinal absorption: comparative assessment of GASTROPLUSTM and IDEATM. European Journal of Pharmaceutical Sciences, 17(1-2), 51-61. Pereira, D.A., Williams, J.A. (2007) Origin and evolution of high throughput screening. British Journal of Pharmacology, 152(1), 53-61. Pillai, V.C., Strom, S.C., Caritis, S.N., Venkataramanan, R., (2013) A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis, 74, 126-132. Plumb, R.S., Potts, W.B. 3rd, Rainville, P.D., Alden, P.G., Shave, D.H., Baynham, G., Mazzeo, J.R., (2008) Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies. Rapid Communications in Mass Spectrometry, 22(14), 2139-2152. Rhodes, S.P., Otten, J.N., Hingorani, G.P., Hartley, D.P., Franklin, R.B., (2011) Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound- mediated induction of CYP3A4, CYP2B6, and CYP1A2. Journal of Pharmacological and Toxicological Methods, 63(3), 223-226. Rodriguez-Aller, M., Gurny, R., Veuthey, J.L., Guillarme, D., (2013) Coupling ultra-high pressure liquid chromatography with mass spectrometry: Constraints and possible applications. Journal of Chromatography A, 1292, 2-18. Saxena, V., Panicucci, R., Joshi, Y., Garad, S., (2008) Developability Assessment in Pharmaceutical Industry: An Integrated Group Approach for Selecting Developable Candidates. Journal of Pharmaceutical Sciences, 98(6), 1962-1979. Spaggiari, D., Geiser, L., Daali, Y., Rudaz, S., (2014) A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologies. Journal of Pharmaceutical and Biomedical Analysis, 101, 221-237 Srinivas N.R. (2008) Changing need for bioanalysis during drug development. Biomedical Chromatography, 22(3), 235-243. Sun, Y., Sun, J., Shi, S., Jing, Y., Yin, S., Chen, Y., Li, G., Xu, Y., He, Z., (2009) Synthesis, Transport and Pharmacokinetics of 5′-Amino Acid Ester Prodrugs of 1-ß-D- Arabinofuranosylcytosine. Molecular Pharmaceutics, 6(1), 315-325. Tamimi, N.A.M., Ellis, P. (2009) Drug Development: From Concept to Marketing! Nephron Clinical Practice, 113(3), c125-c131. van Liempd, S., Morrison, D., Sysmans, L., Nelis, P., Mortishire-Smith, R., (2011) Development and Validation of a Higher-Throughput Equilibrium Dialysis Assay for Plasma Protein Binding. Journal of Laboratory Automation, 16(1), 56-67.